IBSA and Choose Life Biotech, together towards new pioneering therapeutic solutions
IBSA’s know-how together with the expertise of Luca Varani, Laboratory Director at the Research Institute in Biomedicine (IRB, Istituto di Ricerca in Biomedicina) and of manager Vincenzo Martino to develop new research projects in innovative and state-of-the-art fields. This is the goal of the newly founded start-up Choose Life Biotech (CLB), an independent Swiss biotechnology company specialising in the preclinical development of drugs created through molecular engineering.
CLB, in partnership with IBSA, will focus on a biomedical research field that is currently in great expansion: immunotherapy, a therapeutic approach aimed at activating and strengthening the immune system by driving it to attack specific targets (for example, in the oncology field, cancer cells).